$-0.36
(Market cap
$85 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-13
-
Face value
--
-
Shares outstanding
9,361,490
10 Years Aggregate
CFO
$-277.98 Mln
EBITDA
$-147.01 Mln
Net Profit
$-400.44 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Adicet Bio (ACET)
| 3.3 | -4.0 | -6.6 | -24.5 | -32.9 | -41.6 | -- |
|
BSE Sensex*
| -9.0 | -1.3 | 3.1 | -3.4 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Adicet Bio (ACET)
| -45.3 | -48.8 | -78.9 | -48.9 | 24.5 | 34.7 | -82.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
8.7 | 84.8 | 0.0 | -99.0 | -- | -70.9 | -- | 0.7 |
| 82.4 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 263.0 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 70.9 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.6 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 106.5 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 359.4 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 594.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 350.3 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Adicet Bio (ACET)
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel),... is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts. Read more
-
CEO, President & Director
Mr. Chen Schor BA, CPA, M.B.A.
-
CEO, President & Director
Mr. Chen Schor BA, C.P.A., M.B.A.
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Adicet Bio (ACET)
What is the current share price of Adicet Bio Inc (ACET) Today?
The share price of Adicet Bio Inc (ACET) is $8.70 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Adicet Bio Inc (ACET) has given a return of -32.9% in the last 3 years.
What is the current PB & PE ratio of Adicet Bio Inc (ACET)?
Since, TTM earnings of Adicet Bio Inc (ACET) is negative, P/E ratio is not available.
The P/B ratio of Adicet Bio Inc (ACET) is 0.70 times as on 28-Aug-2026, a 86 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.50 |
0.36 |
2024 |
-0.05 |
0.03 |
2023 |
-0.04 |
0.03 |
2023 |
-1.56 |
-0.44 |
2022 |
-0.33 |
0.08 |
What is the 52 Week High and Low of Adicet Bio Inc (ACET)?
The 52-week high and low of Adicet Bio Inc (ACET) are Rs 17.44 and Rs 6.01 as of 01-Sep-2026.
What is the market cap of Adicet Bio Inc (ACET)?
Adicet Bio Inc (ACET) has a market capitalisation of $ 85 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Adicet Bio Inc (ACET)?
Before investing in Adicet Bio Inc (ACET), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.